cancer patients

envie a um amigo share this

Targeting the Immune system and Epigenetic Landscape of Urological Tumors

 

Authors and Affiliations:

João Lobo 1,2,3, Carmen Jerónimo 2,3,*,# and Rui Henrique 1,2,3,*,#

1 Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal

2 Cancer Biology and Epigenetics Group, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP) and Porto Comprehensive Cancer Center (P.CCC), R. Dr. António Bernardino de Almeida, 4200-072, Porto, Portugal

The multi-factorial nature of clinical multidrug resistance in cancer

Several experts from COST Action STRATAGEM - “New diagnostic and therapeutic tools against multidrug resistant tumors”, joined efforts to write an up-to-date, focused and thought-provoking review on the multi-disciplinary and interdisciplinary features of multidrug resistant cancers. It is necessary to identify and understand the various molecular mechanisms behind clinical multidrug resistance, in order to develop new targeted therapeutic strategies to overcome cancer therapeutic failure.

A natureza multifatorial da resistência a múltiplos fármacos anticancerígenos na prática clinica

Vários especialistas da Acção COST STRATAGEM - “New diagnostic and therapeutic tools against multidrug resistant tumors”, reuniram esforços para escrever uma revisão atualizada, desafiante e focada nas características multidisciplinares e interdisciplinares dos cancros com resistência a múltiplos fármacos. É necessário identificar e entender os vários mecanismos moleculares responsáveis pela resistência clínica a múltiplos fármacos anticancerígenos, de modo a desenvolver novas estratégicas terapêuticas dirigidas que permitam ultrapassar a falência da terapêutica.

Molecular Analysis for Personalised Therapy (MAP) Conference

Business Design Centre, London, United Kingdom

 

23 - 24 September, 2016

 

See more informations here: http://www.map-onco.net/

Molecular Analysis for Personalised Therapy (MAP) Conference

Business Design Centre, London, United Kingdom

 

23 - 24 September, 2016

 

See more informations here: http://www.map-onco.net/

6th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer

Rode Hoed’s Great Hall, Amsterdam, Netherlands

 

09-11 May, 2016

 

See more informations here: http://www.eacr.org/mpathcourse2016/index.php

6th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer

Rode Hoed’s Great Hall, Amsterdam, Netherlands

 

09-11 May, 2016

 

See more informations here: http://www.eacr.org/mpathcourse2016/index.php

Acupuncture boosts immunity in cancer patients

Study conducted in two hospitals of Porto revealed that acupuncture has beneficial effects in cancer patients undergoing chemotherapy, including the improvement of the immune system, reduction of chemotherapy side effects, improving the psychoemotional state as well as improving the patients' quality of life.

 

Authors and Affiliations: